UTHR logo

United Therapeutics (UTHR) Shareholders equity

annual shareholders equity:

$6.44B+$459.20M(+7.67%)
December 31, 2024

Summary

  • As of today (May 29, 2025), UTHR annual stockholders equity is $6.44 billion, with the most recent change of +$459.20 million (+7.67%) on December 31, 2024.
  • During the last 3 years, UTHR annual shareholders equity has risen by +$2.49 billion (+62.77%).
  • UTHR annual shareholders equity is now at all-time high.

Performance

UTHR Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRbalance sheet metrics

quarterly shareholders equity:

$6.81B+$363.20M(+5.64%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR quarterly stockholders equity is $6.81 billion, with the most recent change of +$363.20 million (+5.64%) on March 31, 2025.
  • Over the past year, UTHR quarterly shareholders equity has increased by +$1.47 billion (+27.52%).
  • UTHR quarterly shareholders equity is now at all-time high.

Performance

UTHR quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

UTHR Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.7%+27.5%
3 y3 years+62.8%+63.0%
5 y5 years+131.8%+130.9%

UTHR Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+62.8%at high+63.0%
5 y5-yearat high+131.8%at high+130.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

UTHR Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$6.81B(+5.6%)
Dec 2024
$6.44B(+7.7%)
$6.44B(+5.6%)
Sep 2024
-
$6.10B(+7.1%)
Jun 2024
-
$5.70B(+6.7%)
Mar 2024
-
$5.34B(-10.8%)
Dec 2023
$5.98B(+24.8%)
$5.98B(+4.8%)
Sep 2023
-
$5.71B(+5.6%)
Jun 2023
-
$5.41B(+5.6%)
Mar 2023
-
$5.12B(+6.8%)
Dec 2022
$4.80B(+21.2%)
$4.80B(+5.1%)
Sep 2022
-
$4.56B(+5.6%)
Jun 2022
-
$4.32B(+3.4%)
Mar 2022
-
$4.18B(+5.5%)
Dec 2021
$3.96B(+16.6%)
$3.96B(+3.4%)
Sep 2021
-
$3.83B(+5.2%)
Jun 2021
-
$3.64B(+5.6%)
Mar 2021
-
$3.45B(+1.5%)
Dec 2020
$3.40B(+22.1%)
$3.40B(+3.4%)
Sep 2020
-
$3.28B(+6.1%)
Jun 2020
-
$3.09B(+4.9%)
Mar 2020
-
$2.95B(+6.0%)
Dec 2019
$2.78B(-1.0%)
$2.78B(+2.4%)
Sep 2019
-
$2.72B(+5.8%)
Jun 2019
-
$2.57B(+9.8%)
Mar 2019
-
$2.34B(-16.7%)
Dec 2018
$2.81B(+32.4%)
$2.81B(+3.5%)
Sep 2018
-
$2.71B(+4.9%)
Jun 2018
-
$2.58B(+8.2%)
Mar 2018
-
$2.39B(+12.6%)
Dec 2017
$2.12B(+13.9%)
$2.12B(+1.5%)
Sep 2017
-
$2.09B(+16.4%)
Jun 2017
-
$1.80B(-13.5%)
Mar 2017
-
$2.08B(+11.5%)
Dec 2016
$1.86B(+16.4%)
$1.86B(+0.7%)
Sep 2016
-
$1.85B(+1.8%)
Jun 2016
-
$1.82B(+5.5%)
Mar 2016
-
$1.72B(+7.7%)
Dec 2015
$1.60B(+26.4%)
$1.60B(+8.1%)
Sep 2015
-
$1.48B(+40.4%)
Jun 2015
-
$1.05B(-5.3%)
Mar 2015
-
$1.11B(-12.1%)
Dec 2014
$1.27B(-3.0%)
$1.27B(+4.0%)
Sep 2014
-
$1.22B(+0.3%)
Jun 2014
-
$1.21B(-10.7%)
Mar 2014
-
$1.36B(+4.1%)
Dec 2013
$1.30B(+19.1%)
$1.30B(-0.3%)
Sep 2013
-
$1.31B(+7.6%)
Jun 2013
-
$1.22B(+4.7%)
Mar 2013
-
$1.16B(+6.1%)
Dec 2012
$1.09B(+14.1%)
$1.09B(+3.2%)
Sep 2012
-
$1.06B(+5.1%)
Jun 2012
-
$1.01B(-1.5%)
Mar 2012
-
$1.02B(+6.8%)
DateAnnualQuarterly
Dec 2011
$959.37M(+8.5%)
$959.37M(-11.6%)
Sep 2011
-
$1.08B(+8.2%)
Jun 2011
-
$1.00B(+8.5%)
Mar 2011
-
$924.21M(+4.6%)
Dec 2010
$883.89M(+35.4%)
$883.89M(+5.1%)
Sep 2010
-
$840.73M(+7.5%)
Jun 2010
-
$782.30M(+7.4%)
Mar 2010
-
$728.25M(+11.5%)
Dec 2009
$653.01M(+17.6%)
$653.01M(+2.1%)
Sep 2009
-
$639.56M(+5.7%)
Jun 2009
-
$604.98M(+4.8%)
Mar 2009
-
$577.28M(+4.0%)
Dec 2008
$555.33M(+87.7%)
$555.33M(+32.7%)
Sep 2008
-
$418.59M(+15.2%)
Jun 2008
-
$363.41M(+11.3%)
Mar 2008
-
$326.43M(+10.4%)
Dec 2007
$295.79M(+44.6%)
$295.79M(+40.5%)
Sep 2007
-
$210.54M(+17.6%)
Jun 2007
-
$179.00M(+10.3%)
Mar 2007
-
$162.35M(-20.7%)
Dec 2006
$204.61M(-25.6%)
$204.61M(-25.6%)
Sep 2006
-
$275.05M(-8.2%)
Jun 2006
-
$299.52M(+5.0%)
Mar 2006
-
$285.29M(+3.7%)
Dec 2005
$275.10M(+43.6%)
$275.10M(+15.4%)
Sep 2005
-
$238.36M(+9.9%)
Jun 2005
-
$216.80M(+6.6%)
Mar 2005
-
$203.31M(+6.1%)
Dec 2004
$191.64M(+14.2%)
$191.64M(+6.9%)
Sep 2004
-
$179.34M(+5.1%)
Jun 2004
-
$170.59M(+3.4%)
Mar 2004
-
$165.05M(-1.6%)
Dec 2003
$167.76M(-2.3%)
$167.76M(-1.1%)
Sep 2003
-
$169.55M(+0.0%)
Jun 2003
-
$169.47M(+0.7%)
Mar 2003
-
$168.31M(-1.9%)
Dec 2002
$171.66M(-12.6%)
$171.66M(-1.4%)
Sep 2002
-
$174.11M(-6.4%)
Jun 2002
-
$186.04M(-2.5%)
Mar 2002
-
$190.80M(-2.8%)
Dec 2001
$196.40M(-16.3%)
$196.40M(-3.5%)
Sep 2001
-
$203.57M(-4.7%)
Jun 2001
-
$213.59M(-5.0%)
Mar 2001
-
$224.79M(-4.2%)
Dec 2000
$234.74M(+337.9%)
$234.74M(-3.3%)
Sep 2000
-
$242.77M(+111.5%)
Jun 2000
-
$114.81M(-7.1%)
Mar 2000
-
$123.58M(+130.6%)
Dec 1999
$53.60M(+221.0%)
$53.60M(-9.8%)
Sep 1999
-
$59.40M(+1.9%)
Jun 1999
-
$58.30M(+276.1%)
Mar 1999
-
$15.50M
Dec 1998
$16.70M
-

FAQ

  • What is United Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for United Therapeutics?
  • What is United Therapeutics annual shareholders equity year-on-year change?
  • What is United Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for United Therapeutics?
  • What is United Therapeutics quarterly shareholders equity year-on-year change?

What is United Therapeutics annual stockholders equity?

The current annual shareholders equity of UTHR is $6.44B

What is the all time high annual shareholders equity for United Therapeutics?

United Therapeutics all-time high annual stockholders equity is $6.44B

What is United Therapeutics annual shareholders equity year-on-year change?

Over the past year, UTHR annual stockholders equity has changed by +$459.20M (+7.67%)

What is United Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of UTHR is $6.81B

What is the all time high quarterly shareholders equity for United Therapeutics?

United Therapeutics all-time high quarterly stockholders equity is $6.81B

What is United Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, UTHR quarterly stockholders equity has changed by +$1.47B (+27.52%)
On this page